Obesity is an endocrine disorder, not a failure of willpower. We treat it like one — GLP-1 / GIP therapy under specialist supervision, with the safeguards an online pharmacy can't give you.
Clinically supervised GLP-1 therapy can reach 15–22% body-weight reduction. The line below is one illustrative 32-week supervised course — steady, titrated, and held.
Acts on the hypothalamus to quiet cravings and the constant "food noise" that drives overeating.
Stimulates insulin only when glucose is high — improving how the body handles carbohydrate.
Slows stomach emptying so fullness lasts — caloric intake falls without deprivation.
Rapid weight loss can strip lean mass. Our muscle-preservation protocol keeps the loss where it belongs — fat — verified by body composition, not the bathroom scale.
BMIQ — our Body Composition Intelligence Quotient — scores what the scale can't see: body-fat percentage, skeletal muscle mass, visceral fat and waist, read alongside glucose and activity. One 0–100 index that proves you're losing fat and keeping muscle, not just dropping kilos.
GLP-1s are prescription-only for a reason. Specialist supervision is the difference between a transformation and a setback.
Unsupervised rapid loss causes sarcopenia. We run an active muscle-preservation strategy so you lose fat, not strength.
Wrong titration means severe nausea and GI distress. We use a precision-stepped approach to the minimum effective dose.
Not suitable for everyone — e.g. medullary thyroid carcinoma history. We screen before a single dose.
Stop without a metabolic exit plan and weight returns. We build long-term stability into the protocol from day one.
BMI, waist-to-hip ratio and comorbidities — Type 2 diabetes, hypertension, sleep apnea — determine candidacy.
Start low, step up against tolerance and glycemic response. Minimise side effects, maximise efficacy.
GLP-1 handles hunger; you handle fuel. High-protein, nutrient-dense eating supports the new metabolic state.
Regular markers and check-ins tune the dose to the minimum effective level — safe and sustainable.
GLP-1 therapy is prescription-only and not suitable for all patients. Individual results vary.
or message the AiHealth agent, any time.